期刊
EXPERT OPINION ON THERAPEUTIC PATENTS
卷 20, 期 4, 页码 593-596出版社
TAYLOR & FRANCIS LTD
DOI: 10.1517/13543771003662636
关键词
DITPA; metabolic syndrome; thyroid hormone receptor; thyromimetics
The patent application WO2008106213 describes the beneficial effects of thyroid hormone analogue 3,5 diiodothyropropionic acid (DITPA) such as stimulating weight loss in overweight mammals, lowering of triglyceride and treating metabolic syndrome in humans. The human population of the patients selected in the studies mentioned has a body mass index > 25. Two examples of the human clinical studies employing DITPA have been mentioned, namely, the body weight reduction and improvement in metabolic abnormalities in obese adults.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据